Trial · NCT02958865
Results by group1,621
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 1,621
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Total Mayo Score at Week 8 (Induction Period) | Placebo (Induction) | 7.88 | 90% Confidence Interval 6.95 to 8.81 | Units on a scale | |
| Total Mayo Score at Week 8 (Induction Period) | PF-06651600 20 mg (Induction) | 5.85 | 90% Confidence Interval 5.18 to 6.51 | Units on a scale | |
| Total Mayo Score at Week 8 (Induction Period) | PF-06651600 70 mg (Induction) | 4.00 | 90% Confidence Interval 3.33 to 4.67 | Units on a scale | |
| Total Mayo Score at Week 8 (Induction Period) | PF-06651600 200 mg (Induction) | 3.27 | 90% Confidence Interval 2.58 to 3.96 | Units on a scale | |
| Total Mayo Score at Week 8 (Induction Period) | PF-06700841 10 mg (Induction) | 6.08 | 90% Confidence Interval 5.43 to 6.74 | Units on a scale | |
| Total Mayo Score at Week 8 (Induction Period) | PF-06700841 30 mg (Induction) | 5.60 | 90% Confidence Interval 4.93 to 6.27 | Units on a scale | |
| Total Mayo Score at Week 8 (Induction Period) | PF-06700841 60 mg (Induction) | 4.67 | 90% Confidence Interval 4.01 to 5.33 | Units on a scale | |
| Number of Participants With AEs, SAEs and Discontinuation Due to AEs (Chronic Period) | PF-06651600 200 mg -> PF-06651600 50 mg | Participants with AEs | 18 | Participants | |
| Number of Participants With AEs, SAEs and Discontinuation Due to AEs (Chronic Period) | PF-06651600 70 mg -> PF-06651600 50 mg | Participants with AEs | 27 | Participants | |
| Number of Participants With AEs, SAEs and Discontinuation Due to AEs (Chronic Period) | PF-06651600 20 mg -> PF-06651600 50 mg | Participants with AEs | 18 | Participants | |
| Number of Participants With AEs, SAEs and Discontinuation Due to AEs (Chronic Period) | Placebo -> PF-06651600 50 mg | Participants with AEs | 8 | Participants | |
| Number of Participants With AEs, SAEs and Discontinuation Due to AEs (Chronic Period) | PF-06700841 60 mg -> PF-06700841 30 mg | Participants with AEs | 21 | Participants | |
| Number of Participants With AEs, SAEs and Discontinuation Due to AEs (Chronic Period) | PF-06700841 30 mg -> PF-06700841 30 mg | Participants with AEs | 23 | Participants | |
| Number of Participants With AEs, SAEs and Discontinuation Due to AEs (Chronic Period) | PF-06700841 10 mg -> PF-06700841 30 mg | Participants with AEs | 26 | Participants | |
| Number of Participants With AEs, SAEs and Discontinuation Due to AEs (Chronic Period) | Placebo -> PF-06700841 30 mg | Participants with AEs | 4 | Participants | |
| Number of Participants With AEs, SAEs and Discontinuation Due to AEs (Chronic Period) | Pooling Placebo During Chronic | Participants with AEs | 18 | Participants | |
| Number of Participants With AEs, SAEs and Discontinuation Due to AEs (Chronic Period) | PF-06651600 200 mg -> PF-06651600 50 mg | Participants with SAEs | 3 | Participants | |
| Number of Participants With AEs, SAEs and Discontinuation Due to AEs (Chronic Period) | PF-06651600 70 mg -> PF-06651600 50 mg | Participants with SAEs | 1 | Participants | |
| Number of Participants With AEs, SAEs and Discontinuation Due to AEs (Chronic Period) | PF-06651600 20 mg -> PF-06651600 50 mg | Participants with SAEs | 1 | Participants | |
| Number of Participants With AEs, SAEs and Discontinuation Due to AEs (Chronic Period) | Placebo -> PF-06651600 50 mg | Participants with SAEs | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02958865/results